Biological functions


Function Type Function ID Description GeneRatio BgRatio pvalue padjust qvalue GeneCount RABCID
BP GO:0042534 regulation of tumor necrosis factor biosynthetic process 11/1647 34/18670 0.0001031 0.0008283 0.0005007 11 RABC9
BP GO:0014706 striated muscle tissue development 57/1647 390/18670 0.0001041 0.000834 0.0005042 57 RABC9
BP GO:0045445 myoblast differentiation 19/1647 84/18670 0.0001041 0.000834 0.0005042 19 RABC9
BP GO:0033138 positive regulation of peptidyl-serine phosphorylation 22/1647 105/18670 0.0001042 0.000834 0.0005042 22 RABC9
BP GO:0019886 antigen processing and presentation of exogenous peptide antigen via MHC class II 21/1647 98/18670 0.0001059 0.0008456 0.0005112 21 RABC9
BP GO:0045639 positive regulation of myeloid cell differentiation 20/1647 91/18670 0.000106 0.0008456 0.0005112 20 RABC9
BP GO:0007050 cell cycle arrest 39/1647 237/18670 0.0001068 0.000851 0.0005144 39 RABC9
BP GO:0050808 synapse organization 59/1647 408/18670 0.000107 0.0008518 0.0005149 59 RABC9
BP GO:0034504 protein localization to nucleus 42/1647 262/18670 0.0001085 0.0008628 0.0005215 42 RABC9
BP GO:0003018 vascular process in circulatory system 31/1647 173/18670 0.0001092 0.0008671 0.0005241 31 RABC9
BP GO:0022408 negative regulation of cell-cell adhesion 32/1647 181/18670 0.000111 0.0008784 0.000531 32 RABC9
BP GO:0032722 positive regulation of chemokine production 15/1647 58/18670 0.0001111 0.0008784 0.000531 15 RABC9
BP GO:0035306 positive regulation of dephosphorylation 15/1647 58/18670 0.0001111 0.0008784 0.000531 15 RABC9
BP GO:0016331 morphogenesis of embryonic epithelium 28/1647 150/18670 0.0001119 0.0008823 0.0005334 28 RABC9
BP GO:0050777 negative regulation of immune response 28/1647 150/18670 0.0001119 0.0008823 0.0005334 28 RABC9
BP GO:0032930 positive regulation of superoxide anion generation 8/1647 19/18670 0.0001122 0.0008836 0.0005341 8 RABC9
BP GO:0042036 negative regulation of cytokine biosynthetic process 12/1647 40/18670 0.0001148 0.0009027 0.0005457 12 RABC9
BP GO:0070229 negative regulation of lymphocyte apoptotic process 10/1647 29/18670 0.0001162 0.0009117 0.0005511 10 RABC9
BP GO:1902624 positive regulation of neutrophil migration 10/1647 29/18670 0.0001162 0.0009117 0.0005511 10 RABC9
BP GO:0002861 regulation of inflammatory response to antigenic stimulus 9/1647 24/18670 0.0001216 0.0009506 0.0005746 9 RABC9
BP GO:0032897 negative regulation of viral transcription 9/1647 24/18670 0.0001216 0.0009506 0.0005746 9 RABC9
BP GO:0043302 positive regulation of leukocyte degranulation 9/1647 24/18670 0.0001216 0.0009506 0.0005746 9 RABC9
BP GO:2001057 reactive nitrogen species metabolic process 19/1647 85/18670 0.0001232 0.0009614 0.0005811 19 RABC9
BP GO:0046890 regulation of lipid biosynthetic process 34/1647 198/18670 0.0001244 0.0009698 0.0005862 34 RABC9
BP GO:0002548 monocyte chemotaxis 16/1647 65/18670 0.0001254 0.0009763 0.0005901 16 RABC9
BP GO:0010518 positive regulation of phospholipase activity 15/1647 59/18670 0.0001369 0.001062 0.0006421 15 RABC9
BP GO:0046847 filopodium assembly 15/1647 59/18670 0.0001369 0.001062 0.0006421 15 RABC9
BP GO:0061077 chaperone-mediated protein folding 15/1647 59/18670 0.0001369 0.001062 0.0006421 15 RABC9
BP GO:0038061 NIK/NF-kappaB signaling 32/1647 183/18670 0.0001372 0.001063 0.0006425 32 RABC9
BP GO:0003206 cardiac chamber morphogenesis 25/1647 129/18670 0.000138 0.001066 0.0006446 25 RABC9